In the previous few weeks, I’ve obtained just a few emails from folks reporting main shortages of generic oral Minoxidil (and model title Loniten). This is no surprise, since low-dose oral Minoxidil (LDOM) has become all the rage in treating hair loss ever because the well-known NY Times article was printed in August 2022.

Quote from a May 2023 JAMA study:

“The weekly rate of first-time low-dose oral minoxidil prescriptions per 10,000 outpatients was “significantly higher 8 weeks after vs. 8 weeks before article publication,” at 0.9 prescriptions per 10,000, in contrast with 0.5 per 10,000.”

Moreover, a barrage of constructive information tales in relation to LDOM and hair development preserve popping out recurrently. You can take a look at all the newest updates in my most important publish on oral Minoxidil for hair loss.

Generic Oral Minoxidil Shortages

Well recognized hair loss and hair transplant advisor Spexhair first notified me about oral Minoxidil shortages within the UK round a month in the past. Thereafter, a reader e-mailed me and stated that his pharmacy within the US additionally ran out.

Lo and behold, once I went to get my third set of 90 oral Minoxidil capsules a month in the past, the pharmacist advised me that they modified the generic provider. From Sun Pharma (which labored nice for me for six months) to Par Pharmaceutical. I appear to be shedding a bit extra ever since I began with this new refill 🙁

Readers who’re taking oral Minoxidil, please publish your producer/model title within the feedback if attainable. And your hair development outcomes and unwanted effects if attainable.

This complete state of affairs reminds of my travails with generic dutasteride manufacturers that saved altering at my pharmacy. As a consequence, in 2019 I wrote a prolonged publish about my ideas on generic hair loss medication.

Moreover, one of many producers of a generic dutasteride I took even despatched me an fascinating and re-assuring reply. Apparently, that Indian firm’s dutasteride was made within the US.

Loniten No Longer Being Produced?

A few weeks in the past, somebody from Australia e-mailed me that there was a scarcity of oral Minoxidil in Australia. A bit stunning, since that is the nation that’s most accountable for the surge within the reputation of this drug. Courtesy of analysis at Dr. Rodney Sinclair’s clinic in Melbourne. I’m assuming that there isn’t any downside within the provide of their affiliated “The Hairy Pill“.

In any event, this person was more interested in Loniten, which is the brand name of the original oral Minoxidil. He used to take that brand and really wanted to avoid generics. Loniten tablets are made by Pfizer (US) and still listed on their website. Including in their patient information section.

However, when I went to GoodRx and did a search for brand name oral Minoxidil (aka Loniten), I  got the following warning:

Loniten Minoxidil
Loniten tablets (aka brand name oral Minoxidil) discontinued.

They also state the following “Loniten (brand no longer available)” on their main Minoxidil page.

I additionally bear in mind another person mentioning this months in the past, both on a hair loss discussion board or on our hair loss chat. In any case, if you’re somebody who solely trusts the unique model title, you’re out of luck relating to oral Minoxidil.

Perhaps a Temporary Shortage

It can also be attainable that this cessation in provide is momentary. On Canada’s drug shortages web site, it says that there’s a disruption within the manufacture of Loniten as of the final replace in November 2022. However, it additionally provides an “anticipated start date” of August 18, 2023, maybe indicating a possible resumption in manufacturing by Pfizer.


Source by [author_name]

Leave a comment

Your email address will not be published. Required fields are marked *